Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mrinal P. Dutia"'
Autor:
Primo N. Lara, Chong-Xian Pan, David R. Gandara, Thomas Semrad, I-Yeh Gong, Karen Kelly, Mrinal P. Dutia, Tianhong Li, Nichole Mahaffey, Taiwo Akande, Monica Diaz, John S. Bomalaski, James A. Thomson, Benjamin K. Tomlinson
Purpose: This phase I study examined the toxicity and tolerability of pegylated arginine deiminase (ADI-PEG 20) in combination with docetaxel in patients with advanced solid malignancies.Experimental Design: Eligible patients had histologically prove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b989945facad1d88a7e19a5c6644bfb
https://doi.org/10.1158/1078-0432.c.6523874.v1
https://doi.org/10.1158/1078-0432.c.6523874.v1
Autor:
Primo N. Lara, Chong-Xian Pan, David R. Gandara, Thomas Semrad, I-Yeh Gong, Karen Kelly, Mrinal P. Dutia, Tianhong Li, Nichole Mahaffey, Taiwo Akande, Monica Diaz, John S. Bomalaski, James A. Thomson, Benjamin K. Tomlinson
Supplementary Tables S1-S3. Table S1: The complete dose escalation schema for ADI-PEG 20 in combination with docetaxel. Table S2: Details the completed pharmacodynamic data for individual patients. Includes concentrations of arginine and citrulline o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6193c85291168960808a8b86d71ba8cb
https://doi.org/10.1158/1078-0432.22458221.v1
https://doi.org/10.1158/1078-0432.22458221.v1
Publikováno v:
Anti-Cancer Drugs; Jul2013, Vol. 24 Issue 6, p636-640, 5p
